JCM
MNTA

JS Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

JS Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,100
Closed -$268K – 223
2020
Q3 		$268K Buy
+5,100
New +$211K 0.01% 109

JS Capital Management's MNTA Position: Q4 2020 in Review

JS Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 5,100 shares — an estimated $268K sold.

JS Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $268K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • JS Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • JS Capital Management sold 5,100 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $268K.
  • JS Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • JS Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $268K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on JS Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.